Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules

Giovanna Lollo, Kevin Matha, Martina Bocchiardo, Jérôme Bejaud, Ilaria Marigo, Angelique Virgone-Carlotta, Thomas Dehoux, Charlotte Rivière, Jean Paul Rieu, Stephanie Briançon, Thomas Perrier, Olivier Meyer, Jean Pierre Benoit

Research output: Contribution to journalArticle

Abstract

In this work, a novel lipophilic 5-fluorouracil (5-FU) derivative was synthesised and encapsulated into lipid nanocapsules (LNC). 5-FU was modified with lauric acid to give a lipophilic mono-lauroyl-derivative (5-FU-C12, MW of about 342 g/mol, yield of reaction 70%). 5-FU-C12 obtained was efficiently encapsulated into LNC (encapsulation efficiency above 90%) without altering the physico-chemical characteristics of LNC. The encapsulation of 5-FU-C12 led to an increased stability of the drug when in contact with plasma being the drug detectable until 3 h following incubation. Cytotoxicity assay carried out using MTS on 2D cell culture showed that 5-FU-C12-loaded LNC had an enhanced cytotoxic effect on glioma (9L) and human colorectal (HTC-116) cancer cell line in comparison with 5-FU or 5-FU-C12. Then, HCT-116 tumour spheroids were cultivated and the reduction of spheroid volume was measured following treatment with drug-loaded LNC and drugs alone. Similar reduction on spheroids volume was observed following the treatment with drug-loaded LNC, 5-FU-C12 and 5-FU alone, while blank LNC displayed a reduction in cell viability only at high concentration. Globally, our data suggest that the encapsulation increased the activity of the 5-FU-C12. However, in-depth evaluations of LNC permeability into spheroids are needed to disclose the potential of these nanosystems for cancer treatment.

Original languageEnglish
Pages (from-to)1-12
Number of pages13
JournalJournal of Drug Targeting
DOIs
Publication statusAccepted/In press - Nov 21 2018

Keywords

  • 5-Fluorouracil
  • cancer treatment
  • lipid nanoparticles
  • nanomedicine

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules'. Together they form a unique fingerprint.

  • Cite this

    Lollo, G., Matha, K., Bocchiardo, M., Bejaud, J., Marigo, I., Virgone-Carlotta, A., Dehoux, T., Rivière, C., Rieu, J. P., Briançon, S., Perrier, T., Meyer, O., & Benoit, J. P. (Accepted/In press). Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules. Journal of Drug Targeting, 1-12. https://doi.org/10.1080/1061186X.2018.1547733